<PAGE>
------------------------------
OMB APPROVAL
------------------------------
OMB Number
Expires:
Estimated average burden
hours per response ....... 0.5
------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Amendment No. 5)(1)
Altris Software, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
022091 10 2
--------------------------------------------------------------------------------
(CUSIP Number)
Norman L. Smith
Solomon Ward Seidenwurm & Smith, LLP
401 B Street, Suite 1200
San Diego, CA 92101
(619) 231-0303
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
November 14, 2000
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box [_].
Note: Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
(Continued on following pages)
(Page 1 of 4 Pages)
----------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No. 022091 10 2 13D Page 2 of 4 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Spescom Limited
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
AF
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
South Africa
________________________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF 19,092,381
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 19,092,381
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
19,092,381
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
61.9%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
CO
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 022091 10 2 13D Page 3 of 4 Pages
This Amendment No. 5 to Schedule 13D (this "Amendment No. 5") amends and
supplements the Schedule 13D filed by Spescom Limited ("Spescom") by furnishing
the information set forth below. Unless set forth below, all previous Items are
unchanged. Capitalized terms used herein which are not defined herein have the
meanings given to them in the Schedule 13D previously filed with the Securities
and Exchange Commission. Items 3 - 5 are hereby supplemented as follows:
________________________________________________________________________________
Item 3. Source and Amount of Funds or Other Consideration.
On November 14, 2000, Spescom transferred the assets and certain liabilities of
its document management operation, Spescom Ltd. UK in exchange for 550,000
shares of Common Stock of Altris Software, Inc. ("Altris").
The source of the assets transferred in connection with the purchase of the
Altris Common Stock is Spescom's affilliate, Spescom Ltd. UK.
________________________________________________________________________________
Item 4. Purpose of Transaction.
Spescom acquired the Altris Common Stock as a part of a strategic transaction
intended to avail itself of Altris's synergistic technology, established
customer base, and established sales and support infrastructure.
________________________________________________________________________________
Item 5. Interest in Securities of the Issuer.
Spescom will beneficially own an aggregate of 19,092,381 shares of Common Stock
of Altris, which represents approximately 61.9% of the issued and outstanding
shares of Common Stock of Altris. Spescom has the sole power to vote or to
direct the vote and the sole power to dispose or to direct the disposition of
all 19,092,381 shares of Altris Common Stock it beneficially owns.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
08 January 2001
-------------------------------------------
(Date)
/S/ HILTON ISAACMAN
-------------------------------------------
(Signature)
Hilton Isaacman, Director Corporate Finance
-------------------------------------------
(Name/Title)
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).
